Chapter 115: A Stepping Stone in the Medical Field

Hearing his father's words, Liu Xiaodong was initially impatient; after all, for the past twenty-plus years, he had heard similar things too many times.

However.

Thinking of Su Xin's prestige and status, and then thinking of his own wealthy second-generation friends, as well as the way so many netizens at home and abroad held Su Xin in high esteem, a wave of envy surged in his heart.

A life that seemed to shine with such radiance—who wouldn't envy that?

Thinking further of the scenes where many people pointed at him behind his back, disdainfully mocking him as a good-for-nothing, he envied Su Xin's treatment even more.

If I could really have half of Su Xin's...

No, even if it were just ten percent of his achievements, I could become a successful person in everyone's eyes, instead of a useless wealthy second-generation who only knows how to rely on his parents.

With a success story like Su Xin right before his eyes, for the first time, Liu Xiaodong did not feel too repulsed by his father's preaching and began to have the thought of wanting to work hard.

He nodded earnestly:

"Okay, Dad, I will work hard!"

Seeing his unusual behavior, the three members of the Liu family all looked at him in surprise.

Liu Guosong asked even more hesitantly:

"Really? You aren't just trying to curry favor with me to buy some luxury car, are you?"

Liu Xiaodong's expression stiffened; he seemed to feel it was shameful to be spoken to like that by his father in front of Su Xin, and he immediately said with dissatisfaction: "Dad, how could I be that kind of person! I really want to learn from Su Xin and want to have some achievements of my own."

Liu Guosong still didn't quite believe it, but he didn't question him further, only saying: "Then I will have to take a good look at your performance from now on."

Su Xin hurriedly changed the subject and poured a glass of wine for Liu Xiaodong as well:

"Brother Xiaodong is too polite. I'm just an ordinary person; what is there to learn from me? We can just exchange ideas when we have time in the future. Come, Brother Xiaodong, I'll toast you!"

Liu Xiaodong put away the dissatisfaction on his face, piled a bright smile on his face, and raised his glass:

"Come, cheers!"

The few of them clinked glasses and ended today's lunch in a friendly and pleasant atmosphere.

After the meal.

The group sat in the living room chatting for a while, then Su Xin and Liu Guosong went to the study to exchange their insights on their careers.

The richness of Su Xin's knowledge in biomedicine and his profound understanding of biomedical technology left Liu Guosong feeling incredibly shocked.

Liu Guosong's understanding of the overall situation in the biomedical industry also gave Su Xin a great deal of benefit.

"Uncle, I have been researching biomedical technology quite a bit recently, and it's quite broad. I'm a bit indecisive for the moment; if I want to enter the biomedical field, I wonder where it would be best to start?"

Liu Guosong thought seriously for a moment.

Then he said: "There are many promising technologies in the field of biomedicine, but the threshold for entry for the vast majority is very high. Whether it's qualification audits, technical approvals, product launches, or public trust, it all takes a long time to establish."

"After all, biomedicine belongs to the medical industry and concerns human health and safety; even if you can develop a top-tier technology, it is not that easy to put into use."

"If you want to open up the situation quickly, I suggest starting with myopia correction technology."

"According to the statistics from the National Health Commission last year, the total number of people with myopia in Long Country has already exceeded 600 million, nearly half of the total national population. Among them, the myopia rate among teenagers is particularly serious, and it is increasingly showing a trend toward younger ages; it is common to see elementary school students wearing glasses."

"World Health Organization research reports show that the myopia rate among teenagers in Long Country ranks first in the world."

"To a certain extent, myopia has already become a national disease in Long Country. It not only concerns the health of a large number of citizens, especially teenagers, but the country's future high-quality military recruits might also become a big problem, thereby indirectly affecting national security."

"If one could research Non-destructive Myopia Correction Technology from the perspective of biomedicine, it would not only benefit the nation but also win extremely considerable profits."

"Furthermore, this type of technology is relatively easy to verify for actual effects and the presence of sequelae, so it is very suitable as a stepping stone in the medical field."

Su Xin nodded thoughtfully:

"Indeed, the myopia problem is becoming more and more serious in Long Country. For an individual, it might just be an inconvenience, but looking at the whole country, with such a large number of people with myopia, plus the increasingly obvious trend toward younger ages, it is indeed quite serious."

Liu Guosong said solemnly:

"According to last year's World Vision Report, the total number of people with myopia globally is about 2.5 billion. It is predicted that by the year 2050, the global number of people with myopia will reach about 4.9 billion!"

"This is an extremely terrifying social problem, and at the same time, it means that Non-destructive Myopia Correction Technology has an extremely vast market prospect."

"Not to mention anything else, because current myopia technologies generally have obvious sequelae, most myopia patients choose to wear glasses."

"And the total scale of the global eyewear market reached one trillion Long Coins as of 2022!"

"If one could master Non-destructive Myopia Correction Technology, even if one only grabbed half of the market, it could bring in extremely exaggerated profits."

"If the cost of this technology could be lowered to a level that the vast majority of people can afford, it could even completely take over the global myopia glasses market."

Su Xin began to think seriously about this direction.

Although he hadn't paid attention to the myopia problem before, in the process of reading biology books, he had also learned quite a bit of biological knowledge about the eyes.

Now that myopia correction technology was mentioned, several solutions with relatively high feasibility immediately surfaced in his mind.

A moment later, he asked again:

"Uncle, what are the mainstream myopia correction technologies currently?"

Liu Guosong explained carefully: "According to the technical principles, they can be divided into two types: Corneal Refractive Surgery and Intraocular Refractive Surgery."

"The former uses means such as Excimer Laser or Femtosecond Laser to cut the corneal stroma, changing the radius of curvature of the cornea, thereby achieving the purpose of correcting refractive errors and improving corrected vision."

"The latter treats myopia through methods like phakic intraocular lens implantation."

"Based on these two technical principles, many different myopia correction technologies have been derived. Let alone ordinary people not being able to figure them out, even I, as a semi-insider, don't understand the specific differences."

"But there is one thing everyone knows: these myopia surgeries have more or less safety hazards, and the surgeries are complex and expensive."

"The most important thing is that there are sequelae."

"This is a shortcoming that all myopia correction surgeries cannot avoid."

"Therefore, the choice of the vast majority of people with myopia is to wear glasses; the wealthier they are, the more they resist these surgeries."

"Many people say that myopia is irreversible and that no matter what technology it is, it is impossible to repair a myopic eye without damage."

"But there are also many insiders who look to the future, believing that there is a method that can correct vision without damage, and that is to let the eyeball actively adjust and self-repair from a biological perspective."